Impact of bacterial and viral coinfection in community-acquired pneumonia in adults

Abstract Bacterial and viral coinfected community-acquired pneumonia (CAP) is poorly characterized in adults. The aim of this study was to investigate the influence of bacterial and viral coinfection in patients with CAP. A total of 235 adults who requested molecular tests of pneumonia and were diagnosed with CAP were enrolled in this study. Microbiological tests included blood and sputum cultures, PCR for bacterial and viral pathogens, antigen test for Streptococcus pneumoniae and the influenza virus, and antibody detection of Mycoplasma pneumonia. Of the 235 patients, 32 (13.6%) patients were coinfected with bacteria and virus. Among 64 severe CAP patients, the concurrent infections were confirmed in 14 patients (21.9%). The proportion of severe pneumonia was significantly higher in patients with coinfection, and they showed a significantly higher mortality rate. In conclusion, bacterial and viral coinfection in CAP is not a rare occurrence in adults. Viral and bacterial coinfections have an adverse impact on the severity of the pneumonia, and increase morbidity and mortality in patients with CAP.

[1]  E. Sanders,et al.  Viral and Bacterial Interactions in the Upper Respiratory Tract , 2013, PLoS pathogens.

[2]  D. Murdoch,et al.  Incidence and characteristics of viral community-acquired pneumonia in adults , 2007, Thorax.

[3]  W. Lim,et al.  Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study , 2003, Thorax.

[4]  M. Fine,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[5]  T. Welte,et al.  Clinical and economic burden of community-acquired pneumonia among adults in Europe , 2010, Thorax.

[6]  W. Lim,et al.  BTS guidelines for the management of community acquired pneumonia in adults: update 2009 , 2009, Thorax.

[7]  Y. Shemer-Avni,et al.  Respiratory Viruses in Adults With Community-Acquired Pneumonia , 2010, Chest.

[8]  Sheldon P Stone,et al.  Community-acquired pneumonia , 1998, The Lancet.

[9]  Y. Yazdanpanah,et al.  Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia , 2016, Critical Care.

[10]  J. Vincent,et al.  Increased incidence of co-infection in critically ill patients with influenza , 2016, Intensive Care Medicine.

[11]  A. Buiting,et al.  Viral and bacterial aetiology of community‐acquired pneumonia in adults , 2012, Influenza and other respiratory viruses.

[12]  P. Horby,et al.  The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review , 2014, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[13]  S. Clarke,et al.  Secondary Bacterial Infections Associated with Influenza Pandemics , 2017, Front. Microbiol..

[14]  E. Claas,et al.  Improved Diagnosis of the Etiology of Community-Acquired Pneumonia with Real-Time Polymerase Chain Reaction , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Daniel S. Chertow,et al.  Bacterial coinfection in influenza: a grand rounds review. , 2013, JAMA.

[16]  C. Chiu,et al.  Impact of bacterial and viral coinfection on mycoplasmal pneumonia in childhood community-acquired pneumonia. , 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[17]  E. Klein,et al.  The frequency of influenza and bacterial coinfection: a systematic review and meta‐analysis , 2016, Influenza and other respiratory viruses.

[18]  T. Wiemken,et al.  Incidence of respiratory viruses in patients with community-acquired pneumonia admitted to the intensive care unit: results from the Severe Influenza Pneumonia Surveillance (SIPS) project , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[19]  T. Ala-Kokko,et al.  Lower Respiratory Tract Virus Findings in Mechanically Ventilated Patients With Severe Community-Acquired Pneumonia , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  Michael J Fine,et al.  Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  A. Kalil,et al.  Pneumonia with bacterial and viral coinfection , 2017, Current opinion in critical care.

[23]  古谷 良輔,et al.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.

[24]  J. McCullers.  Insights into the Interaction between Influenza Virus and Pneumococcus , 2006, Clinical Microbiology Reviews.

[25]  C. Esquinas,et al.  Microbial aetiology of community-acquired pneumonia and its relation to severity , 2011, Thorax.